New scan analysis may predict chemo failure in pancreatic cancer
NCT ID NCT07243288
First seen Nov 21, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study looks at 400 adults with metastatic pancreatic cancer to see if a new imaging method called radiomics can predict early who will not respond to chemotherapy. Researchers will analyze CT scans to find patterns linked to survival. The goal is to help doctors adjust treatment sooner for better outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.